- $93.8 million of series 2015 bonds
- $16.3 million of series 2012A and 2012B bonds
- $21.2 million of series 2008(a) bonds
- $9.8 million of series 2007A and 2007B bonds
- $39.7 million of series 2006(a) bonds
The rating affirmation incorporates a number of factors, including CHS’ regional growth and adequate balance sheet.
The outlook is stable.
More articles on healthcare finance:
Colo. representative demands explanation for $1B cost overruns for VA hospital
60% of hospitals at risk of CCJR cost penalties, study finds
S&P revises Nash Health Care Systems’ outlook to negative
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
